1. Home
  2. ITGR vs ALVO Comparison

ITGR vs ALVO Comparison

Compare ITGR & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITGR
  • ALVO
  • Stock Information
  • Founded
  • ITGR 1970
  • ALVO 2013
  • Country
  • ITGR United States
  • ALVO Luxembourg
  • Employees
  • ITGR N/A
  • ALVO N/A
  • Industry
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ALVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITGR Health Care
  • ALVO Health Care
  • Exchange
  • ITGR Nasdaq
  • ALVO Nasdaq
  • Market Cap
  • ITGR 4.1B
  • ALVO 3.4B
  • IPO Year
  • ITGR 2000
  • ALVO N/A
  • Fundamental
  • Price
  • ITGR $113.52
  • ALVO $8.46
  • Analyst Decision
  • ITGR Strong Buy
  • ALVO Buy
  • Analyst Count
  • ITGR 9
  • ALVO 1
  • Target Price
  • ITGR $148.56
  • ALVO $18.00
  • AVG Volume (30 Days)
  • ITGR 649.5K
  • ALVO 125.6K
  • Earning Date
  • ITGR 04-24-2025
  • ALVO 05-20-2025
  • Dividend Yield
  • ITGR N/A
  • ALVO N/A
  • EPS Growth
  • ITGR 25.44
  • ALVO N/A
  • EPS
  • ITGR 3.37
  • ALVO N/A
  • Revenue
  • ITGR $1,716,596,000.00
  • ALVO $491,978,000.00
  • Revenue This Year
  • ITGR $10.86
  • ALVO $17.94
  • Revenue Next Year
  • ITGR $7.41
  • ALVO $53.52
  • P/E Ratio
  • ITGR $34.47
  • ALVO N/A
  • Revenue Growth
  • ITGR 10.35
  • ALVO 426.85
  • 52 Week Low
  • ITGR $107.11
  • ALVO $9.15
  • 52 Week High
  • ITGR $146.36
  • ALVO $14.76
  • Technical
  • Relative Strength Index (RSI)
  • ITGR 33.67
  • ALVO 22.45
  • Support Level
  • ITGR $113.52
  • ALVO $9.15
  • Resistance Level
  • ITGR $121.56
  • ALVO $9.90
  • Average True Range (ATR)
  • ITGR 3.58
  • ALVO 0.38
  • MACD
  • ITGR 0.34
  • ALVO -0.21
  • Stochastic Oscillator
  • ITGR 18.55
  • ALVO 3.96

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: